Showing 21,061 - 21,080 results of 31,227 for search '(( significant decrease decrease ) OR ( significant ((rate increased) OR (teer decrease)) ))', query time: 0.64s Refine Results
  1. 21061

    Data Sheet 3_Efficacy and safety of sorafenib combined with transarterial chemoembolization in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled t... by Lixiu Yu (2558290)

    Published 2025
    “…The 12-month overall survival (OS) was also significantly increased by combination therapy [OR = 3.18, 95%CI (2.41,4.19), P < 0.00001]. …”
  2. 21062

    Data Sheet 1_Promoting healthy aging through intergenerational exchange and digital empowerment: a pilot randomized controlled trial.pdf by Giulia Cossu (3837568)

    Published 2025
    “…Feasibility outcomes showed an overall dropout rate of 28.57%, similarly to comparable trials. Notably, the attrition rate was lower in the experimental group (16.67%). …”
  3. 21063

    Table 2_Systematic analysis and prediction of the burden of Alzheimer’s disease and other dementias caused by hyperglycemia.xlsx by Dongying He (4747362)

    Published 2025
    “…The mortality rate from HFPG-ADOD increased by 305.81%. The primary burden was among the 80–84 age group. …”
  4. 21064

    Image 2_Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma.tif by Liu-Xia Yuan (18007980)

    Published 2025
    “…Additionally, DAP3 expression significantly increased in both tissue samples and cell lines. …”
  5. 21065

    Data Sheet 4_Efficacy and safety of sorafenib combined with transarterial chemoembolization in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled t... by Lixiu Yu (2558290)

    Published 2025
    “…The 12-month overall survival (OS) was also significantly increased by combination therapy [OR = 3.18, 95%CI (2.41,4.19), P < 0.00001]. …”
  6. 21066

    Data Sheet 2_Efficacy and safety of sorafenib combined with transarterial chemoembolization in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled t... by Lixiu Yu (2558290)

    Published 2025
    “…The 12-month overall survival (OS) was also significantly increased by combination therapy [OR = 3.18, 95%CI (2.41,4.19), P < 0.00001]. …”
  7. 21067

    Table 1_Clinical characteristics and risk factors for Mycoplasma pneumoniae pneumonia in children.docx by Xueqi Zhao (2593480)

    Published 2024
    “…Compared to NMPP group, MPP group exhibited higher levels of platelet count (PLT), heparin-binding protein (HBP), erythrocyte sedimentation rate (ESR), immunoglobulin G (IgG) (P < 0.05). The levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum ferritin (SF), prothrombin time (PT), fibrinogen (Fg), interleukin-5 (IL-5) and Gamma interferon (IFN-γ) were significantly increased in SMPP group compared to MMPP group. …”
  8. 21068

    Table 1_Systematic analysis and prediction of the burden of Alzheimer’s disease and other dementias caused by hyperglycemia.xlsx by Dongying He (4747362)

    Published 2025
    “…The mortality rate from HFPG-ADOD increased by 305.81%. The primary burden was among the 80–84 age group. …”
  9. 21069

    Table 1_Association of cardiorespiratory fitness with risk of adverse cardiovascular outcomes in cancer patients: a cohort study.docx by Yutong Wang (3852589)

    Published 2025
    “…</p>Results<p>RHR is significantly associated with an increased risk of adverse events (HF: HR = 1.013, 95% CI 1.008–1.019, P < 0.001; CTR_CVT: HR = 1.006, 95% CI 1.004–1.008, P < 0.001), except for AF (HR = 0.998, 95% CI 0.994–1.001, P = 0.194). …”
  10. 21070

    Supplementary Material for: A Retrospective Comparison of Postoperative Tumor Necrosis Factor-α Inhibitors Continuation Versus Ustekinumab Switch in Crohn's Disease: Reset or Switc... by figshare admin karger (2628495)

    Published 2025
    “…A medical claims database analysis confirmed no significant difference in the cumulative clinical recurrence-free rate (log-rank test; P = 0.232) or subsequent intestinal surgery-free rate (log-rank test; P = 0.554) between the TNFi continuation group and the UST switch group. …”
  11. 21071

    Table 1_A higher ratio of IL-2/IL-4 may be an early predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.docx by Yu Fu (16582)

    Published 2025
    “…TNF-α (day +7) and IL-2 (day +28) significantly increased in grade I aGVHD. After excluding sepsis and ES cases, 19 had aGVHD (12 grade I and 7 grade II–IV aGVHD). …”
  12. 21072

    Data Sheet 1_Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study.pdf by Na Zhou (123019)

    Published 2024
    “…Further exploration found that a group of peripheral lymphocyte subsets increased significantly after 2 cycles of neoadjuvant therapy in patients who achieved pCR, suggesting the importance of dynamic monitoring of circulating lymphocyte.…”
  13. 21073

    Data Sheet 1_Global, regional, and national trends and burden of hypertensive disorders in pregnancy among women of childbearing age from 1990 to 2021.pdf by Zhongyun Tang (21287855)

    Published 2025
    “…Prevalence and incidence rates increased (EAPCs: −0.7 and −0.67), while mortality and DALYs rates decreased (EAPCs: −2.29 and −2.28). …”
  14. 21074

    Table 1_Global, regional, and national trends and burden of hypertensive disorders in pregnancy among women of childbearing age from 1990 to 2021.xlsx by Zhongyun Tang (21287855)

    Published 2025
    “…Prevalence and incidence rates increased (EAPCs: −0.7 and −0.67), while mortality and DALYs rates decreased (EAPCs: −2.29 and −2.28). …”
  15. 21075

    Table 1_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Join-point analysis revealed an increasing trend in age-standardized prevalence rates between 1990 and 2021, while mortality and DALYs rates decreased. …”
  16. 21076

    Table 4_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Join-point analysis revealed an increasing trend in age-standardized prevalence rates between 1990 and 2021, while mortality and DALYs rates decreased. …”
  17. 21077

    Image 1_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.tif by Ning An (618997)

    Published 2025
    “…Join-point analysis revealed an increasing trend in age-standardized prevalence rates between 1990 and 2021, while mortality and DALYs rates decreased. …”
  18. 21078

    Table 3_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Join-point analysis revealed an increasing trend in age-standardized prevalence rates between 1990 and 2021, while mortality and DALYs rates decreased. …”
  19. 21079

    Table 2_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Join-point analysis revealed an increasing trend in age-standardized prevalence rates between 1990 and 2021, while mortality and DALYs rates decreased. …”
  20. 21080

    Appendix 2 - Tools and Outcomes from the Hybrid Roleplay Intervention by Dinus Salam (20306184)

    Published 2024
    “…The Documentation Quality Assessment Tool (DQAT) showed significant improvements in the completeness of assessments, accuracy of SOAP notes, and timeliness of documentation, with high expert ratings for organization and readability. …”